10 March 2026
Radovanovic96/Getty ImagesBy Ella Pickover, PA Media
Two major UK trials have provided robust evidence that artificial intelligence can significantly improve breast cancer screening outcomes whilst substantially reducing radiologist workload
The MIA (Mammography Intelligent Assessment) AI trial found the use of AI could increase detection of disease by 10.4% compared to standard human-only review.